Evaluation of liquid culture for quantitation of Mycobacterium tuberculosis in murine models.

Evaluation of liquid culture for quantitation of Mycobacterium tuberculosis in murine models.

Show other versions (1)

Quantitation of bacterial load in tissues is essential for experimental investigation of Mycobacterium tuberculosis infection and immunity. We have used an automated liquid culture system to determine the number of colony forming units (CFU) in murine tissues and compared the results to those obtain...

Descrición completa

Detalles Bibliográficos
Main Authors:	O'Sullivan, D, Sander, C, Shorten, R, Gillespie, S, Hill, A, McHugh, T, McShane, H, Tchilian, E
Formato:	Journal article
Idioma:	English
Publicado:	2007

Títulos similares

Evaluation of liquid culture for quantitation of Mycobacterium tuberculosis in murine models.
por: O'Sullivan, D, et al.
Publicado: (2007)

Immunogenicity and protective efficacy of prime-boost regimens with recombinant (delta)ureC hly+ Mycobacterium bovis BCG and modified vaccinia virus ankara expressing M. tuberculosis antigen 85A against murine tuberculosis.
por: Tchilian, E, et al.
Publicado: (2009)

Erratum: Immunogenicity and protective efficacy of prime-boost regimens with recombinant δureC hly+ Mycobacterium bovis BCG and modified Vaccinia virus Ankara expressing M. tuberculosis antigen 85A against murine tuberculosis
por: Tchilian, E, et al.
Publicado: (2011)

Immunogenicity and Protective Efficacy of Prime-Boost Regimens with Recombinant Delta ureC hly(+) Mycobacterium bovis BCG and Modified Vaccinia Virus Ankara Expressing M. tuberculosis Antigen 85A against Murine Tuberculosis, (vol 77, pg 630, 2009)
por: Tchilian, E, et al.
Publicado: (2011)

Mycobacterial growth inhibition in murine splenocytes as a surrogate for protection against Mycobacterium tuberculosis (M. tb)
por: Marsay, L, et al.
Publicado: (2013)

A novel murine cytomegalovirus vaccine vector protects against Mycobacterium tuberculosis.
por: Beverley, P, et al.
Publicado: (2014)

New tuberculosis vaccines can diminish as well as enhance BCG induced protection: Results from a murine model
por: Sander, C, et al.
Publicado: (2006)

Multifunctional, high-level cytokine-producing Th1 cells in the lung, but not spleen, correlate with protection against Mycobacterium tuberculosis aerosol challenge in mice.
por: Forbes, E, et al.
Publicado: (2008)

Vaccines for tuberculosis
por: McShane, H
Publicado: (2013)

Mycobacterial growth inhibition in murine splenocytes as a surrogate for protection against Mycobacterium tuberculosis (M. tb).
por: Marsay, L, et al.
Publicado: (2013)

Human and Bovine Tuberculosis
por: McShane, H
Publicado: (2016)

Cholera toxin enhances vaccine-induced protection against Mycobacterium tuberculosis challenge in mice
por: Griffiths, K, et al.
Publicado: (2013)

Th1/Th17 cell induction and corresponding reduction in ATP consumption following vaccination with the novel Mycobacterium tuberculosis vaccine MVA85A.
por: Griffiths, K, et al.
Publicado: (2011)

Th1/Th17 cell induction and corresponding reduction in ATP consumption following vaccination with the novel mycobacterium tuberculosis vaccine MVA85A
por: Griffiths, K, et al.
Publicado: (2011)

A human challenge model for Mycobacterium tuberculosis using Mycobacterium bovis bacille Calmette-Guérin
por: Minassian, A, et al.
Publicado: (2012)

A human challenge model for Mycobacterium tuberculosis using Mycobacterium bovis bacille Calmette-Guerin.
por: Minassian, A, et al.
Publicado: (2012)

Spot sputum samples are at least as good as early morning samples for identifying Mycobacterium tuberculosis.
por: Murphy, M, et al.
Publicado: (2017)

Insights and challenges in tuberculosis vaccine development
por: McShane, H
Publicado: (2019)

Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in Mycobacterium tuberculosis-infected individuals.
por: Sander, C, et al.
Publicado: (2009)

Non-tuberculous mycobacteria have diverse effects on BCG efficacy against Mycobacterium tuberculosis
por: Poyntz, H, et al.
Publicado: (2014)

Tuberculosis vaccines: beyond bacille Calmette–Guérin
por: McShane, H
Publicado: (2011)

Tuberculosis vaccines: Beyond bacilli Calmette-Guérin
por: McShane, H
Publicado: (2011)

Tuberculosis vaccines: Progress and challenges
por: Checkley, A, et al.
Publicado: (2011)

Elevated IgG responses in infants are associated with reduced prevalence of Mycobacterium tuberculosis infection
por: Logan, E, et al.
Publicado: (2018)

Local pulmonary immunological biomarkers in tuberculosis
por: Morrison, H, et al.
Publicado: (2021)

Rapid detection of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells.
por: Lalvani, A, et al.
Publicado: (2001)

Controlled human infection models: is it really feasible to give people tuberculosis?
por: McShane, H
Publicado: (2020)

Improving tuberculosis vaccine trial efficiency: a tough nut to crack
por: McShane, H
Publicado: (2023)

High frequencies of circulating IFN-gamma-secreting CD8 cytotoxic T cells specific for a novel MHC class I-restricted Mycobacterium tuberculosis epitope in M. tuberculosis-infected subjects without disease.
por: Pathan, A, et al.
Publicado: (2000)

Why don’t we have an effective tuberculosis vaccine yet?
por: Davenne, T, et al.
Publicado: (2016)

Challenges in developing a controlled human tuberculosis challenge model
por: Jackson, S, et al.
Publicado: (2022)

Quantitative association tests of immune responses to antigens of Mycobacterium tuberculosis: a study of twins in West Africa.
por: Wiart, A, et al.
Publicado: (2004)

Boosting with poxviruses enhances Mycobacterium bovis BCG efficacy against tuberculosis in guinea pigs.
por: Williams, A, et al.
Publicado: (2005)

Inflammation and immune activation are associated with risk of Mycobacterium tuberculosis infection in BCG-vaccinated infants
por: Satti, I, et al.
Publicado: (2022)

Molecular genotyping of mycobacterium tuberculosis associated with extrapulmonary tuberculosis
por: Ayub, Nur Izzah Farakhin
Publicado: (2015)

Development of Tools to Quantitatively Probe Mycobacterium tuberculosis-induced Host Phagosomal and Signaling Responses
por: Solomon, Sydney Leigh
Publicado: (2023)

Clinical testing of tuberculosis vaccine candidates
por: Hatherill, M, et al.
Publicado: (2016)

CD8+ T cell-mediated suppression of intracellular Mycobacterium tuberculosis growth in activated human macrophages.
por: Brookes, R, et al.
Publicado: (2003)

Viral booster vaccines improve Mycobacterium bovis BCG-induced protection against bovine tuberculosis.
por: Vordermeier, H, et al.
Publicado: (2009)

A phase IIa trial of the new tuberculosis vaccine, MVA85A, in HIV- and/or Mycobacterium tuberculosis-infected adults.
por: Scriba, T, et al.
Publicado: (2012)